Stockreport

Seelos Therapeutics Receives FDA Fast Track Designation for Intranasal Racemic Ketamine (SLS-002)

Seelos Therapeutics, Inc.  (SEEL) 
Last seelos therapeutics, inc. earnings: 5/21 05:12 pm Check Earnings Report
PDF NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapie [Read more]